Discontinuation report CLONAZEPAM
Report ID | 28145 |
Drug Identification Number | 02442027 |
Brand name | CLONAZEPAM |
Common or Proper name | CLONAZEPAM |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLONAZEPAM |
Strength(s) | 0.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AE |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-11-01 |
Remaining supply date | 2017-11-05 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-06 | English | Compare |
v2 | 2017-11-06 | French | Compare |
Showing 1 to 2 of 2